1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow AP026 (TQA2226) for injection: new trials by email Literature Review of AP026 (TQA2226) for injection trials Research Report on AP026 (TQA2226) for injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Trial of AP026 (TQA2226) for Injection in Adult Subjects. AP026 (TQA2226) for injection, AP026 (TQA2226) for injection matching placebo - Diabetes Mellitus, Type 2 | Phase 1 | Terminated | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 14 | 2023-05-24 | 2026-04-22 |
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. (1)
China (1)